Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Broadcom
AVGO
|
+$1.43B |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$805M |
| 3 |
Meta Platforms (Facebook)
META
|
+$713M |
| 4 |
Amazon
AMZN
|
+$688M |
| 5 |
Tesla
TSLA
|
+$525M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.96B |
| 2 |
Spotify
SPOT
|
+$1.22B |
| 3 |
Microsoft
MSFT
|
+$847M |
| 4 |
Apollo Global Management
APO
|
+$757M |
| 5 |
Workday
WDAY
|
+$444M |
Sector Composition
| 1 | Technology | 15.78% |
| 2 | Financials | 14.57% |
| 3 | Healthcare | 12.51% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3826
NextCure
NXTC
$14.2M
| $32.8K | ﹤0.01% |
3,543
-2,467
| -41% | -$22.8K |
|
3827
AEye
LIDR
$104M
| $32.2K | ﹤0.01% |
+25,380
| New | +$32.2K |
|
3828
IZEA Worldwide
IZEA
$61.7M
| $31.6K | ﹤0.01% |
11,473
+951
| +9% | +$2.62K |
|
3829
SCYNEXIS
SCYX
$49.9M
| $31.3K | ﹤0.01% |
+25,887
| New | +$31.3K |
|
|
EPRX
3830
Eupraxia Pharmaceuticals
EPRX
$200M
| $31.3K | ﹤0.01% |
+10,000
| New | +$31.3K |
|
|
HOOK
3831
DELISTED
HOOKIPA Pharma
HOOK
| $30.8K | ﹤0.01% |
+15,326
| New | +$30.8K |
|
3832
Cytosorbents Corp
CTSO
$61.2M
| $30.3K | ﹤0.01% |
+33,280
| New | +$30.3K |
|
|
NIU
3833
Niu Technologies
NIU
$322M
| $30K | ﹤0.01% |
16,766
-56,138
| -77% | -$100K |
|
|
IPM
3834
Intelligent Protection Management Corp. Common Stock
IPM
$24.9M
| $29.8K | ﹤0.01% |
+14,950
| New | +$29.8K |
|
3835
Solarmax Technology
SMXT
$60.8M
| $29.5K | ﹤0.01% |
18,183
-160,452
| -90% | -$260K |
|
3836
Dyadic International
DYAI
$35.5M
| $28.3K | ﹤0.01% |
+16,193
| New | +$28.3K |
|
|
XNET
3837
Xunlei
XNET
$472M
| $27.6K | ﹤0.01% |
13,865
-4,289
| -24% | -$8.54K |
|
3838
Atossa Therapeutics
ATOS
$106M
| $27.5K | ﹤0.01% |
+29,149
| New | +$27.5K |
|
3839
Applied DNA Sciences
APDN
$3.27M
| $27.5K | ﹤0.01% |
+180
| New | +$27.5K |
|
|
ORIS
3840
Oriental Rise Holdings Limited Ordinary Shares
ORIS
$4.34M
| $27K | ﹤0.01% |
+17,650
| New | +$27K |
|
3841
Flux Power
FLUX
$30.5M
| $27K | ﹤0.01% |
+17,075
| New | +$27K |
|
3842
Altisource Portfolio Solutions
ASPS
$127M
| $26.3K | ﹤0.01% |
5,008
-3,053
| -38% | -$16.1K |
|
|
SUP
3843
DELISTED
Superior Industries International
SUP
| $26.3K | ﹤0.01% |
12,898
-1,119
| -8% | -$2.28K |
|
3844
Anixa Biosciences
ANIX
$96M
| $25.6K | ﹤0.01% |
+11,028
| New | +$25.6K |
|
3845
Mesa Air Group
MESA
$58.2M
| $25.3K | ﹤0.01% |
+21,769
| New | +$25.3K |
|
3846
Bolt Biotherapeutics
BOLT
$10.2M
| $25.2K | ﹤0.01% |
+2,351
| New | +$25.2K |
|
3847
VCI Global
VCIG
$24.3M
| $24.9K | ﹤0.01% |
+707
| New | +$24.9K |
|
3848
Onconetix
ONCO
$4.9M
| $24.9K | ﹤0.01% |
+464
| New | +$24.9K |
|
3849
Yatra Online
YTRA
$90.5M
| $24.7K | ﹤0.01% |
+19,639
| New | +$24.7K |
|
|
AHG
3850
Akso Health Group
AHG
$1.01B
| $24.5K | ﹤0.01% |
+18,004
| New | +$24.5K |
|